PW MEDTECH (01358) repurchased 194,000 shares for HK$176,400 on October 13.
PW MEDTECH (01358) announced that on October 13, 2026, the company repurchased 194,000 shares for HK$176,400, at a repurchase price of HK$0.905-0.915 per share.
PW MEDTECH (01358) announced that on October 13, 2026, the company repurchased 194,000 shares for HK$176,400, at a repurchase price of HK$0.905-0.915 per share.
Related Articles
Zelgen Biopharmaceutical (688266.SH): New Drug Application for Gecacitinib Hydrochloride Tablets for the Treatment of Active Ankylosing Spondylitis Accepted
Services and wealth management businesses become key "engine"! Citigroup (C.US) Q3 net profit surges 40% year-over-year, EPS beats expectations.
Tower Semiconductor Ltd(TSEM.US) and Semtech Corporation(SMTC.US) Expand Collaboration to Secure Silicon Germanium Capacity for AI Data Center Connectivity
Zelgen Biopharmaceutical (688266.SH): New Drug Application for Gecacitinib Hydrochloride Tablets for the Treatment of Active Ankylosing Spondylitis Accepted
Services and wealth management businesses become key "engine"! Citigroup (C.US) Q3 net profit surges 40% year-over-year, EPS beats expectations.
Tower Semiconductor Ltd(TSEM.US) and Semtech Corporation(SMTC.US) Expand Collaboration to Secure Silicon Germanium Capacity for AI Data Center Connectivity
